Stents Market is Anticipated to Cross US$ 19.50 Billion by 2024

New York, April 15, 2019: The scope of the report includes a detailed study of global and regional markets on Global Stents Market with the reasons given for variations in the growth of the industry in certain regions.

The Global Stents Market is expected to exceed more than US$ 19.50 Billion by 2024 at a CAGR of 9.5% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., C. R. Bard, Inc, Elixir Medical Corp., Medtronic plc, Microport Scientific Corp., Stentys S.A., Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

You Can Browse Full Report @:

A stent is a small and tiny wire web like tube that a special medical practitioner implants in the body of the patient in order to restore blood flow and support the vessel wall. Stents help to keep the coronary arteries open in order to decrease the rate of a heart attack. A stent reinstates the blood flow and flow of other fluids, based on where the stent is placed. One of the significant causes behind growing cardiovascular conditions is getting habitual to unhealthy lifestyle. Evolving way of life, for example, smoking, physical inactivity, and irregular eating habits hamper the health of the heart. These conditions are prompting probability of hypertension, stoutness, and blockages in supply routes. Thus, aging of population is another element that is driving the development of these items at a critical rate. The use of latest trends in medical field, for example, scaffolds, Bioresorbable stents, bifurcation stent, and biodegradable polymer with an appropriation of more up to date systems and negligibly intrusive strategies are inclining in this industry. These items are optional for bypass surgery. What’s more, when utilized as a part of insignificantly obtrusive methods, they offer certain points of interest over traditional surgeries, for example, less recovery time, shorter scars, less physical injury and less danger of infection and less bleeding.

The Global Stents Market has been segmented as below:

The Global Stents Market is Segmented on the lines of Material Analysis, Type Analysis and Regional Analysis. By Material Analysis this market is segmented on the basis of Metallic Biomaterials, Polymers Biomaterials and Natural Biomaterials.

By Type Analysis this market is segmented on the basis of Coronary Stents its covers Drug-Eluting Stents (DES), Bare-Metal Coronary Stents &Bioabsorbable Stents. Peripheral Stents its covers Iliac, Femoral-Popliteal, Renal & Carotid. Stent-Related Implants its covers Synthetic Grafts & Vena Cava Filters. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Stents Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Stents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Stents Market are as follows:

  • Growing ageing population and rising prevalence of chronic diseases
  • New developing technological advancements in the field of stents
  • Development of healthcare infrastructure in developing countries
  • Enhanced insurance and repayment

The restraining factors of Global Stents Market are as follows:

  • High cost of treatment related with stent implants
  • Strict approval process for stents
  • Availability of optional treatment method

Request Sample Report from here:

Table of Contents

1 Introduction

2 Executive Summary

3 Market Overview

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers Growing geriatric population and increasing prevalence of chronic diseases Technological advancements in the field of stents Improvement of healthcare infrastructure in developing countries Improved insurance and reimbursement

3.5.2 Restraints High cost of treatment associated with stent implants Stringent approval process for stents

3.5.3 Opportunities Huge market opportunities in the developing countries

4 World Stents Market, By Product

5 World Stents Market, By Biomaterial

5.1 Overview

5.1.1 Market size and forecast

5.2 Metallic biomaterials

5.2.1 Market size and forecast

5.3 Polymeric biomaterials

5.3.1 Market size and forecast

5.4 Natural biomaterials

5.4.1 Market size and forecast

6 World Stents Market, By Geography

7 Company Profiles

7.1 Abbott Laboratories

7.2 B. Braun Melsungen Ag

7.3 Biotronik Se & Co. Kg

7.4 Boston Scientific Corporation

7.5 C. R. Bard, Inc.

7.6 Elixir Medical Corporation

7.7 Medtronic Plc

7.8 Microport Scientific Corporation

7.9 Stentys S.A.

7.10 Terumo Corporation

Other Related Market Research Reports:

Spirometer Market is Expected to Get US$ 1.00 Billion by 2024

Sleep Apnea Devices Market is Forecast to Cross US$ 6.5 Billion By 2022

Sports Medicine Devices Market is Supposed to Reach US$ 9 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States


Add Comment